Open an account

Parabilis Medicines

PBLS · NASDAQ

$27.08+$1.73 (+6.82%)TodayMarket closed ·
Prev close $25.35

Latest news

  • NewsAvi Kapoor

    Silence Therapeutics, Disc Medicine, Veradermics And Other Big Stocks Moving Higher On Monday

  • Press releaseGlobe Newswire

    Parabilis Medicines Initiates Dose-Ranging Clinical Study of Zolucatetide in Familial Adenomatous Polyposis

  • Press releaseGlobe Newswire

    Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors

  • Press releaseGlobe Newswire

    Parabilis Medicines Reports Second Quarter 2026 Financial Results and Provides Business Updates

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.